Oncology

The Pharmacy Times® Oncology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?

Combination Therapy Demonstrates Promising Antitumor Activity

These study results were announced by Eisai and Merck during the 2020 American Society of Clinical Oncology Virtual Scientific Program, May 29-31.

How Specialty Pharmacies Can Improve Transitional Care Amid COVID-19

As clinicians, we must first understand the unique challenges that a patient is facing and then tailor our support to address their specific needs.

Value-Based Oncology Care Offers Clinical Opportunities for Pharmacists

Pharmacists can deliver value-based oncology services as an integral part of the health care team to improve patient outcomes.

An Overview of Epithelioid Sarcoma

Sarcomas account for about 1% of all adult cancers and 15% of all pediatric cancers.

Why Generics Matter More Than Ever Before in Today’s Specialty Pharmacies

Many pharmacies may be missing significant, profitable opportunities...via generic pharmaceuticals.

Researchers Analyze Neutropenia During Venetoclax Monotherapy in Patients With R/R CLL

The investigators found that patients with preexisting neutropenia could be managed on venetoclax, although use of G-CSF would likely also be required in conjunction with the treatment.

Study Shows Breast Cancer on the Rise Globally

Both premenopausal and postmenopausal breast cancer rates are rising globally.

Ensuring Patient Access to Oncology Care During the COVID-19 Pandemic

Although the treatment of cancer is facing many challenges, the pandemic is also creating massive amounts of new data with which to educate patients, conduct new research, and make more informed clinical decisions.

Webcast: Cancer Care Updates in the Era of COVID-19

This Pharmacy Times Webcast provides an overview of how the COVID-19 pandemic has impacted the treatment and management of patients with cancer.

Systemic Therapy Options for Treating HR+/HER2– Metastatic Breast Cancer

Following initial breast cancer diagnosis by mammography, MRI, or ultrasound, treatment is largely based upon the histologic subtype and staging of the tumor(s).

Securing Specialty Oncology Contracts in a Data-Driven World

Data aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.

Value-Based Contracting in Oncology

Meaningful breakthrough therapies are receiving accelerated approval based on evidence of impact on a surrogate end point rather than evidence of impact on the actual clinical benefit for which the drug is intended.

The Pharmacy Times® Hematology specialty page serves as a hub for all clinical news and articles related to hematological conditions. The coverage includes updates from the floor of all the biggest societal conferences and annual meetings, like the American Society of Hematology Annual Meeting, as well as video interviews of the leading hematologists and key opinion leaders in the space.